Lindsey R Hayes (Lindsey Hayes)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Oxidative Stress

High Throughput

Top Venues

bioRxiv : the preprint server for biology

Nature neuroscience

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yini Li, Xiaoyang Dou, Jun Liu, Yu Xiao, Zhe Zhang, Lindsey R Hayes, Rong Wu, Xiujuan Fu, Yingzhi Ye, Bing Yang, Lyle W Ostrow, Chuan He, Shuying Sun
Globally reduced N 6 -methyladenosine (m 6 A) in C9ORF72-ALS/FTD dysregulates RNA metabolism and contributes to neurodegeneration. Nature neuroscience (2023)
Yini Li, Xiaoyang Dou, Jun Liu, Yu Xiao, Zhe Zhang, Lindsey R Hayes, Rong Wu, Xiujuan Fu, Yingzhi Ye, Bing Yang, Lyle W Ostrow, Chuan He, Shuying Sun
Globally reduced N 6 -methyladenosine (m 6 A) in C9ORF72-ALS/FTD dysregulates RNA metabolism and contributes to neurodegeneration. Nature neuroscience (2023)
Xi Zhang, Tanuza Das, Petr Kalab, Lindsey R Hayes
Multivalent GU-rich oligonucleotides sequester TDP-43 in the nucleus by inducing high molecular weight RNP complexes. bioRxiv : the preprint server for biology (2023)
Patricia M Dos Passos, Erandika H Hemamali, Lohany D Mamede, Lindsey R Hayes, Yuna M Ayala
RNA-mediated ribonucleoprotein assembly controls TDP-43 nuclear retention. bioRxiv : the preprint server for biology (2023)
Xiuli Yang, Lindsey R Hayes
Order from chaos: Using CSF proteomics to predict ALS progression. Annals of clinical and translational neurology (2023)
Lindsey R Hayes, Petr Kalab
Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 19 (4) (2022)
Lindsey R Hayes, Lauren Duan, Kelly Bowen, Petr Kalab, Jeffrey D Rothstein
C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import. eLife 9 (2020)